Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Tacrine and its 7-methoxy derivate; time-change concentration in plasma and brain tissue and basic toxicological profile in rats

J. Zdarova Karasova, O. Soukup, J. Korabecny, M. Hroch, M. Krejciova, M. Hrabinova, J. Misik, L. Novotny, V. Hepnarova, K. Kuca

. 2021 ; 44 (2) : 207-214. [pub] 20190701

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004572

The search for tacrine derivatives, as potential Alzheimer´s disease treatment, is still being at the forefront of scientific efforts. 7-MEOTA was found to be a potent, centrally active acetylcholinesterase inhibitor free of the serious side effects observed for tacrine. Unfortunately, a relevant argumentation about pharmacokinetics and potential toxicity is incomplete; information about tacrine derivatives absorption and especially CNS penetration are still rare as well as detailed toxicological profile in vivo. Although the structural changes between these compounds are not so distinctive, differences in plasma profile and CNS targeting were found. The maximum plasma concentration were attained at 18th min (tacrine; 38.20 ± 3.91 ng/ml and 7-MEOTA; 88.22 ± 15.19 ng/ml) after i.m. application in rats. Although the brain profiles seem to be similar; tacrine achieved 19.34 ± 0.71 ng/ml in 27 min and 7-MEOTA 15.80 ± 1.13 ng/ml in 22 min; the tacrine Kp (AUCbrain/AUCplasma) fit 1.20 and was significantly higher than 7-MEOTA Kp 0.10. Administration of tacrine and 7-MEOTA showed only mild elevation of some biochemical markers following single p.o. application in 24 hours and 7 days. Also histopathology revealed only mild-to-moderate changes following repeated p.o. administration for 14 days. It seems that small change in tacrine molecule leads to lower ability to penetrate through the biological barriers. The explanation that lower p.o. acute toxicity of 7-MEOTA depends only on differences in metabolic pathways may be now revised to newly described differences in pharmacokinetic and toxicological profiles.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004572
003      
CZ-PrNML
005      
20220127145140.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1080/01480545.2019.1566350 $2 doi
035    __
$a (PubMed)31257938
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zdarova Karasova, Jana $u Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, University of Defence, Hradec Kralove, Czech Republic $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
245    10
$a Tacrine and its 7-methoxy derivate; time-change concentration in plasma and brain tissue and basic toxicological profile in rats / $c J. Zdarova Karasova, O. Soukup, J. Korabecny, M. Hroch, M. Krejciova, M. Hrabinova, J. Misik, L. Novotny, V. Hepnarova, K. Kuca
520    9_
$a The search for tacrine derivatives, as potential Alzheimer´s disease treatment, is still being at the forefront of scientific efforts. 7-MEOTA was found to be a potent, centrally active acetylcholinesterase inhibitor free of the serious side effects observed for tacrine. Unfortunately, a relevant argumentation about pharmacokinetics and potential toxicity is incomplete; information about tacrine derivatives absorption and especially CNS penetration are still rare as well as detailed toxicological profile in vivo. Although the structural changes between these compounds are not so distinctive, differences in plasma profile and CNS targeting were found. The maximum plasma concentration were attained at 18th min (tacrine; 38.20 ± 3.91 ng/ml and 7-MEOTA; 88.22 ± 15.19 ng/ml) after i.m. application in rats. Although the brain profiles seem to be similar; tacrine achieved 19.34 ± 0.71 ng/ml in 27 min and 7-MEOTA 15.80 ± 1.13 ng/ml in 22 min; the tacrine Kp (AUCbrain/AUCplasma) fit 1.20 and was significantly higher than 7-MEOTA Kp 0.10. Administration of tacrine and 7-MEOTA showed only mild elevation of some biochemical markers following single p.o. application in 24 hours and 7 days. Also histopathology revealed only mild-to-moderate changes following repeated p.o. administration for 14 days. It seems that small change in tacrine molecule leads to lower ability to penetrate through the biological barriers. The explanation that lower p.o. acute toxicity of 7-MEOTA depends only on differences in metabolic pathways may be now revised to newly described differences in pharmacokinetic and toxicological profiles.
650    _2
$a zvířata $7 D000818
650    _2
$a plocha pod křivkou $7 D019540
650    _2
$a mozek $x metabolismus $7 D001921
650    _2
$a cholinesterasové inhibitory $x aplikace a dávkování $x farmakokinetika $x toxicita $7 D002800
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a takrin $x aplikace a dávkování $x analogy a deriváty $x farmakokinetika $x toxicita $7 D013619
650    _2
$a časové faktory $7 D013997
650    _2
$a tkáňová distribuce $7 D014018
655    _2
$a časopisecké články $7 D016428
700    1_
$a Soukup, Ondrej $u Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, University of Defence, Hradec Kralove, Czech Republic $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Korabecny, Jan $u Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, University of Defence, Hradec Kralove, Czech Republic $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Hroch, Milos $u Faculty of Medicine, Department of Medicinal Biochemistry, Charles University in Prague, Hradec Kralove, Czech Republic
700    1_
$a Krejciova, Marketa $u Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, University of Defence, Hradec Kralove, Czech Republic
700    1_
$a Hrabinova, Martina $u Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, University of Defence, Hradec Kralove, Czech Republic $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Misik, Jan $u Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, University of Defence, Hradec Kralove, Czech Republic $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Novotny, Ladislav $u Finn Pathologists, One Eyed Lane, Weybread, UK
700    1_
$a Hepnarova, Vendula $u Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, University of Defence, Hradec Kralove, Czech Republic $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Kuca, Kamil $u Biomedical Research Centre, University Hospital, Hradec Kralove, Czech Republic $u Faculty of Science, Department of Chemistry, University of Hradec Kralove, Hradec Kralove, Czech Republic $u Department of Cellular Biology and Pharmacology, Florida International University, Miami, FL, USA
773    0_
$w MED00001436 $t Drug and chemical toxicology $x 1525-6014 $g Roč. 44, č. 2 (2021), s. 207-214
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31257938 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145137 $b ABA008
999    __
$a ok $b bmc $g 1751888 $s 1155721
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 44 $c 2 $d 207-214 $e 20190701 $i 1525-6014 $m Drug and chemical toxicology $n Drug Chem Toxicol $x MED00001436
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace